Chinook Therapeutics is a biotechnology company that specializes in developing precision medicines for kidney diseases. They have a lead clinical program called atrasentan, for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Chinook Therapeutics is based in Seattle, Washington, and also has other product candidates for rare and severe chronic kidney diseases.